Page last updated: 2024-08-16

protoporphyrin ix and methotrexate

protoporphyrin ix has been researched along with methotrexate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anand, S; Chang, Y; Hasan, T; Mai, Z; Maytin, EV; Ortel, BJ; Sinha, AK	1
Anand, S; Elson, P; Hasan, T; Honari, G; Maytin, EV	1

Other Studies

2 other study(ies) available for protoporphyrin ix and methotrexate

Article	Year
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. British journal of cancer, 2006, Aug-21, Volume: 95, Issue:4 Topics: Aminolevulinic Acid; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coproporphyrinogen Oxidase; Humans; Male; Methotrexate; Metribolone; Models, Biological; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Up-Regulation	2006
Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10 Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Antimetabolites, Antineoplastic; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; Coproporphyrinogen Oxidase; Dose-Response Relationship, Drug; Ferrochelatase; Filaggrin Proteins; Humans; Keratinocytes; Light; Methotrexate; Mice; Mice, Nude; Neoplasms, Experimental; Photochemotherapy; Protoporphyrins; Skin Neoplasms; Xenograft Model Antitumor Assays	2009

Article

Year

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.

British journal of cancer, 2006, Aug-21, Volume: 95, Issue:4

Topics: Aminolevulinic Acid; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coproporphyrinogen Oxidase; Humans; Male; Methotrexate; Metribolone; Models, Biological; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Up-Regulation

2006

Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Antimetabolites, Antineoplastic; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; Coproporphyrinogen Oxidase; Dose-Response Relationship, Drug; Ferrochelatase; Filaggrin Proteins; Humans; Keratinocytes; Light; Methotrexate; Mice; Mice, Nude; Neoplasms, Experimental; Photochemotherapy; Protoporphyrins; Skin Neoplasms; Xenograft Model Antitumor Assays

2009